Shanghai Pharmaceuticals Holding Co Ltd - ESG Rating & Company Profile powered by AI
This assessment of Shanghai Pharmaceuticals Holding Co Ltd employs data from across the web as well as from available filings by Shanghai Pharmaceuticals Holding Co Ltd. Comprehensive ESG assessment of Shanghai Pharmaceuticals Holding Co Ltd are reached by logging in. Jump to the bottom of this webpage for potential risks for Shanghai Pharmaceuticals Holding Co Ltd based on sector, geography and marketcap.
Shanghai Pharmaceuticals Holding Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Shanghai Pharmaceuticals Holding Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Shanghai Pharmaceuticals Holding Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose current and historical energy intensity?
Does Shanghai Pharmaceuticals Holding Co Ltd report the average age of the workforce?
Does Shanghai Pharmaceuticals Holding Co Ltd reference operational or capital allocation in relation to climate change?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose its ethnicity pay gap?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose cybersecurity risks?
Does Shanghai Pharmaceuticals Holding Co Ltd offer flexible work?
Does Shanghai Pharmaceuticals Holding Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose the number of employees in R&D functions?
Does Shanghai Pharmaceuticals Holding Co Ltd conduct supply chain audits?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Shanghai Pharmaceuticals Holding Co Ltd conduct 360 degree staff reviews?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose the individual responsible for D&I?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose current and / or historical scope 2 emissions?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose water use targets?
Does Shanghai Pharmaceuticals Holding Co Ltd have careers partnerships with academic institutions?
Did Shanghai Pharmaceuticals Holding Co Ltd have a product recall in the last two years?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose incidents of discrimination?
Does Shanghai Pharmaceuticals Holding Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Shanghai Pharmaceuticals Holding Co Ltd issued a profit warning in the past 24 months?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose parental leave metrics?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose climate scenario or pathway analysis?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose the pay ratio of women to men?
Does Shanghai Pharmaceuticals Holding Co Ltd support suppliers with sustainability related research and development?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Shanghai Pharmaceuticals Holding Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Shanghai Pharmaceuticals Holding Co Ltd involved in embryonic stem cell research?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose GHG and Air Emissions intensity?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose its waste policy?
Does Shanghai Pharmaceuticals Holding Co Ltd report according to TCFD requirements?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose energy use targets?
Does Shanghai Pharmaceuticals Holding Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Shanghai Pharmaceuticals Holding Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Shanghai Pharmaceuticals Holding Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.